Rob Kastelein
- Immunology top 0.5%
- Immune Cell Function and Interaction 6
- Psoriasis: Treatment and Pathogenesis 4
- Immunotherapy and Immune Responses 4
- Immunology and Allergy top 2%
- Oncology top 2%
- CAR-T cell therapy research 5
- Dermatology top 2%
- Virology top 5%
-
- RNA and protein synthesis mechanisms 8
- Viral Infectious Diseases and Gene Expression in Insects 5
-
- Bacteriophages and microbial interactions 5
-
- Bacterial Genetics and Biotechnology 5
- Co-authors
- René de Waal MalefytKevin W. MooreJ E de VriesHergen SpitsHans YsselCarl G. FigdorJohn B.A.G. HaanenMaria Grazia Roncarolo
- Journals
- The Journal of Immunology (5 papers)European Journal of Biochemistry (3 papers)Cancer Research (3 papers)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Rob Kastelein
37 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Immunology 4.0k
- Immunology and Allergy 351
- Oncology 1.3k
- Dermatology 293
- Virology 139
Countries citing papers authored by Rob Kastelein
This map shows the geographic impact of Rob Kastelein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Kastelein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Kastelein more than expected).
Fields of papers citing papers by Rob Kastelein
This network shows the impact of papers produced by Rob Kastelein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Kastelein. The network helps show where Rob Kastelein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rob Kastelein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 0 | |
| 3 | 2021 | 61 | |
| 4 | 2012 | 220 | |
| 5 | 2009 | 181 | |
| 6 | 2009 | 47 | |
| 7 | 2009 | 22 | |
| 8 | 2005 | 59 | |
| 9 | 2004 | 111 | |
| 10 | IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκBbreakdown → | 1997 | 620 |
| 11 | 1996 | 46 | |
| 12 | 1996 | 20 | |
| 13 | 1995 | 11 | |
| 14 | Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.breakdown → | 1991 | 1685 |
| 15 | 1990 | 3 | |
| 16 | 1990 | 13 | |
| 17 | 1990 | 423 | |
| 18 | 1988 | 53 | |
| 19 | 1988 | 143 | |
| 20 | 1983 | 28 |
About Rob Kastelein
Rob Kastelein is a scholar working on Immunology, Oncology, Endocrinology, Molecular Biology and Genetics, having authored 38 papers that have together received 6.4k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (8 papers), Immune Cell Function and Interaction (6 papers), Bacteriophages and microbial interactions (5 papers), CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Bacterial Genetics and Biotechnology (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (4.0k citations), Immunology and Allergy (351 citations), Oncology (1.3k citations), Dermatology (293 citations) and Virology (139 citations). Rob Kastelein has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include René de Waal Malefyt, Kevin W. Moore, J E de Vries, Hergen Spits, Hans Yssel, Carl G. Figdor, John B.A.G. Haanen, Maria Grazia Roncarolo, Keith Johnson and Tim R. Mosmann. Their work appears in journals such as The Journal of Immunology, European Journal of Biochemistry, Cancer Research, Gene and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.